Hynion AS: Status of the restructuring and expression of interest from an investor group

Oslo, 8. September 2026 - Hynion AS ("Hynion" or the "Company") provides the
following update on its ongoing restructuring.

Over the past months the Company has worked on a restructuring comprising
several creditors. Although most creditors have accepted agreements, the Company
has not been able to attract the investor interest required to fund the
settlement within the deadline set forth. Creditors who have entered into such
agreements will be asked to agree that the agreement is replaced by the offer
described below.

As announced on 27 August 2026, the Company has received a letter dated 26
August 2026 from Euronext Oslo Børs stating that the exchange will consider
whether the Company's shares should be delisted, and the Company has been given
a deadline of 9 September 2026 to explain what measures may be taken for the
Company to again become suitable for listing. The Company will respond within
the deadline.

The Company has today received an expression of interest from Modiola AS and
Middelborg Invest AS (together the "Investor Group"), together interested in
acquiring the majority of the shares in the Company. 

Following completion, the Investor Group has indicated that it intends to
propose a redirection of the Company's business towards virtual private server
(VPS) and dedicated server hosting, and to seek to place an equity issue
intended to provide the Company with the capital required to settle the
liabilities that are not converted, other liabilities arising from the
restructuring, the ongoing operation of the Company and the establishment of the
new business, and to fund continued operations.

In the board's assessment, the offer is attractive in the circumstances and
represents a tangible opportunity to secure any value on behalf of the Company's
creditors.
The Company will contact each of the Company's creditors within the deadline for
acceptance stated in the offer made to that creditor. The offer made to each
creditor depends on the category into which its claim falls, as set out below.
Each creditor whose claim is to be converted will enter into two agreements: an
agreement with the Company under which the claim is converted into shares and
all further claims against the Company are waived; and an agreement with the
Investor Group for the sale of the shares resulting from that conversion, at the
price stated in the offer.

All outstanding amounts subject to the restructuring, other than the claims of
the critical suppliers, will be converted to equity. The conversion price will
be NOK 0.001 per share, following a reduction of the par value, to be resolved
by the general meeting. The terms of the subsequent sale to the Investor Group
depend on the category into which the claim falls. The guarantee claim of Bizcap
AB and Gerhard Dahl, established by judgment and arising from a guarantee for
the obligations of the Company's bankrupt Swedish subsidiary, is dealt with in a
separate agreement under which NOK 1,000,000 is paid for the shares resulting
from conversion of that claim in full. Ordinary creditors are offered 15 per
cent of their outstanding claim, paid for the shares resulting from conversion.
The guarantee claim and the ordinary creditors are the creditors who convert,
and the cash they receive is paid by the Investor Group and not by the Company.
 
Critical suppliers, whose services the Company requires in order to meet its
statutory reporting obligations and its obligations as a company admitted to
trading, do not convert; they are dealt with in individual agreements providing
for settlement in full by the Company itself, out of the proceeds of the equity
issue, after completion. 
The offer assumes, subject to verification, that the guarantee claim accounts
for approximately NOK 15.6 million, the ordinary creditors for approximately NOK
7.8 million and the critical suppliers for approximately NOK 1.1 million. The
Company's general manager, Lavrans Grjotheim, converts on the same terms through
Galileo Ventures AS and Axon AS. He sells part of the resulting shares at the
same price per share as every other ordinary creditor and retains the balance,
save for a shareholding amounting to 7.5% of the outstanding shares
post-conversion. 

On the basis of that conversion price, and before the equity issue, the
Company's existing shareholders would together hold approximately 3.1 per cent
of the Company following conversion. 

Creditors representing approximately 80 per cent of the claims to be converted
have indicated support for the structure.

All offers will be subject to the following conditions precedent, and no cash
settlement will be made to any creditor before all of them have been fulfilled:

1. the creditors having enterede into agreements on conversion and sale of
shares on terms satisfactory to the Investor Group;

2. the Company's 2025 and H1 2026 financial report having been completed and
published;

3. the completion of an equity issue raising the capital which, in the Investor
Group's assesment, is 
required to settle the liabilities that are not converted and other liabilities
arising from the restructuring, the ongoing operation of the Company and the
establishment of the new business, and to provide the Company with positive book
Equity and sufficient working capital;

4. no petition in bankruptcy having been filed and no enforcement or attachment
having been levied against the Company;

5. no material adverse change in the Company's financial position, liabilities
or legal standing, including any fine, penalty charge, sanction, order or notice
of compulsory 	dissolution, and no material breach by the Company of statutory,
accounting or marketplace obligations; and

6. Euronext Oslo Børs confirming that the transaction, taken as a whole,
satisfies the requirements for continued listing, trading in the Company's
shares having resumed on Euronext Growth Oslo, and the shares having been
removed from the Recovery Box and the Penalty Bench.


Any of the conditions may be waived, but only by the Investor Group acting
jointly.

The Company will revert with further information as the process develops.

This information is subject to the disclosure requirements pursuant to the EU
Market Abuse Regulation.
ny will revert with further information as the process develops.\
\
This information is subject to the disclosure requirements pursuant to the EU\
Market Abuse Regulation.\